Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04999267 · ClinicalTrials.gov registry record · NA

Increasing Vaccine Uptake Among Adolescents in the Rural South

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
2
Enrollment target

NCT04999267: Completed NA study, sponsored by Duke University.

NCT04999267 is a NA study that has completed, run by Duke University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04999267, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

The benefits of adolescent vaccines are well known for preventing meningococcal infection and human papillomavirus (HPV)-related pre-cancerous lesions. Yet, many adolescents in the United States (US) remain under-vaccinated, with vaccination rates among rural adolescents significantly lower than among their urban peers. In addition, there are urban-rural disparities in the coverage of HPV vaccine, particularly in Southern states like North and South Carolina, which currently fall below the Healthy People 2020 goal of ≥80% coverage. The goal of the proposed study is to evaluate the feasibility and preliminary efficacy of a school-based intervention for increasing vaccine uptake among adolescents in rural North and South Carolina.

Primary Outcome

HPV vaccination status (received at least one versus no doses) of middle schoolers (by district) will be obtained from official vaccination records before and after intervention implementation.

Interventions

  • OTHER INVEST

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2021-08-31
Est. Completion 2022-11-03
Phase NA
Duke University

1,725 total trials

What the finished NCT04999267 record still lists

NCT04999267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which INVEST is the first listed.

NCT04999267 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04999267 about?

NCT04999267 is a clinical study titled "Increasing Vaccine Uptake Among Adolescents in the Rural South". The benefits of adolescent vaccines are well known for preventing meningococcal infection and human papillomavirus (HPV)-related pre-cancerous lesions. Yet, many adolescents in the United States (US) remain under-vaccinated, with vaccination rates among rural adolescents significantly lower than amo...

What is the current status of trial NCT04999267?

This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2021-08-31. Estimated completion is 2022-11-03.

What interventions are being tested in trial NCT04999267?

The interventions under investigation include: INVEST (OTHER).

Who is sponsoring clinical trial NCT04999267?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04999267's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04999267, the US trial registry maintained by the National Library of Medicine. NCT04999267 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.